DIA 2013 49th Annual Meeting
Click here to go to the previous page
Clinical Outcome Assessment for Clinical Trials: PROs, ClinROs, and ObsROs
Track : Track 19: Communities Showcase
Program Code: 362
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 205A
CHAIR :
 Melvyn Greberman, MD,MPH,MS,FACPM (SCHNON), President, Public Health Resources, United States
SPEAKER (S):
 Elektra Johanna Papadopoulos, DrMed,MPH (SPKAGY), Medical Officer, Office of New Drugs, CDER, FDA, United States
 Stanley A. Edlavitch, PhD,MA (SPKSUP), Professor, Epidemiology, School of Medicine; Center for Behavioral Medicine, University of Missouri Kansas City, United States
 J. Michael Fitzmaurice, PhD,FACMI (SPKAGY), Senior Science Advisor for Information Technology, Office of the Director, Agency for Healthcare Research and Quality (AHRQ), United States
Description
This session will discuss the use of patient-reported outcomes (PROs), clinician-reported outcomes (ClinROs), and observer-reported outcomes (ObsROs) to assess treatment benefits in clinical trials, and collaborative ventures that support scientific, regulatory, and clinical applications in the US and other countries.

This session has been developed by the Clinical Research Community.